Search

Illumina Inc

Abierto

SectorSanidad

217.47 -0.54

Resumen

Variación precio

24h

Actual

Mínimo

211.6

Máximo

221.49

Métricas clave

By Trading Economics

Ingresos

-268M

-134M

Ventas

68M

1.2B

P/B

Media del Sector

35.568

57.371

BPA

1.31

Margen de beneficios

-11.562

Empleados

8,600

EBITDA

80M

330M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

-11.15% downside

Dividendos

By Acuity

Próximas Ganancias

29 oct 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

497M

29B

Apertura anterior

218.01

Cierre anterior

217.47

Noticias sobre sentimiento de mercado

By Acuity

28%

72%

80 / 340 Clasificación en Healthcare

Illumina Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

21 ago 2026, 19:16 UTC

Illumina Inc shares are higher today, recovering from earlier losses and remaining above the 20-day moving average for the third consecutive session.

20 ago 2026, 20:02 UTC

Illumina Inc's shares are higher today, building on gains since Wednesday. The stock is trading near the upper end of its one-month range.

19 ago 2026, 20:02 UTC

Correlated Moves

Illumina Inc. shares are higher, buoyed by strong momentum in the genomics sector and a notable rise in the ARK Genomic Revolution ETF.

17 ago 2026, 19:54 UTC

News

Illumina Inc's stock is higher, supported by a Yahoo Finance article discussing its price target of $198.89 and concerns over organic sales performance.

13 ago 2026, 20:06 UTC

Illumina Inc's shares are lower amid declines in the Life Sciences Tools & Services sector, with no specific company news identified for the movement.

12 ago 2026, 22:02 UTC

Illumina Inc shares are lower in after-market hours with no specific news identified. Broader market conditions reflect mixed performance amid inflation data.

11 ago 2026, 19:16 UTC

Illumina Inc. shares are trading higher, recovering from an early dip during Tuesday's session. No specific news or developments were identified.

10 ago 2026, 23:16 UTC

Correlated Moves

Illumina Inc shares fell in after-hours trading, tracking a broader decline in the Russell 2000 Index amid rising U.S. Treasury yields and inflation concerns.

7 ago 2026, 19:46 UTC

News

Illumina Inc shares are lower after Director Keith A. Meister sold 283,269 shares, raising investor concerns about the company's valuation.

6 ago 2026, 23:06 UTC

Illumina Inc shares are lower in after-market trading following Thursday's close, despite an initial uptick. No specific news was identified to explain the decline.

5 ago 2026, 19:52 UTC

Correlated Moves

Illumina shares are lower following disappointing first-quarter results and broader market declines. ADP's report on weak job growth has added to cautious sentiment.

4 ago 2026, 19:31 UTC

Correlated Moves

Illumina Inc's shares are higher today, reflecting a broader market trend as the Russell 2000 Index also advances. The stock is near its one-month range high.

3 ago 2026, 20:03 UTC

News

Illumina shares are lower today as Citigroup maintains a Sell rating and raises its price target to $113 amid mixed analyst sentiment.

31 jul 2026, 23:06 UTC

News

Illumina Inc reported strong Q2 results and raised full-year guidance, yet shares declined in after-market trading from Friday's close of $202.95.

30 jul 2026, 23:41 UTC

News
Social Media

Illumina Inc shares declined in after-market trading despite strong second-quarter results and raised full-year EPS guidance, reflecting concerns over falling net income.

29 jul 2026, 23:26 UTC

Illumina Inc. shares declined after-market amid overall market volatility following the Federal Reserve's decision to maintain interest rates amid rising inflation concerns.

28 jul 2026, 19:46 UTC

News

Illumina Inc. is acquiring contingent payments from its merger with Treeline Biosciences to enhance integration. Shares are trading higher since Monday's close.

27 jul 2026, 23:26 UTC

Illumina Inc shares are lower in after-market hours, continuing a decline over the past three sessions with no specific news identified.

24 jul 2026, 17:46 UTC

Illumina Inc's shares are lower today, hitting a mid-morning low. Broader market sentiment may be affected by recent volatility in oil prices.

22 jul 2026, 19:31 UTC

News

Illumina Inc shares are lower amid a report citing stagnant sales and concerns over management's investment opportunities. The company may need acquisitions for growth.

21 jul 2026, 20:02 UTC

Correlated Moves
News

Illumina Inc's shares are higher, supported by broader market momentum and anticipation of upcoming earnings from major companies. The Russell 2000 Index also advanced.

20 jul 2026, 19:56 UTC

Correlated Moves

Illumina Inc shares declined during Monday's session, paralleling a drop in the ARK Genomic Revolution ETF amid broader market weakness.

17 jul 2026, 19:06 UTC

Illumina Inc shares are lower today amid broader market declines, particularly in technology and semiconductor stocks, following significant selling pressure in Asia.

16 jul 2026, 22:06 UTC

Illumina Inc shares are lower in after-market hours, tracking broader market declines amid geopolitical tensions and mixed economic indicators.

15 jul 2026, 18:51 UTC

Illumina Inc shares declined Wednesday, pulling back from earlier gains. No specific news was identified to explain this movement amid broader positive market trends.

14 jul 2026, 19:36 UTC

News

Illumina shares rise as Canaccord raises price target to $190.00, despite a patent ruling against the company in Germany.

10 jul 2026, 20:06 UTC

Correlated Moves

Illumina Inc shares are lower amid a broader decline in the biotechnology sector. Market volatility is heightened due to geopolitical tensions involving the U.S. and Iran.

9 jul 2026, 19:11 UTC

News
Correlated Moves

Illumina Inc. appointed Mike Sullivan as Chief Commercial Officer and Julie Coletti as Chief Legal Officer, contributing to a rise in shares amid sector gains.

8 jul 2026, 20:04 UTC

Correlated Moves

Illumina Inc shares are lower today, influenced by declines in the Life Sciences Tools & Services sector and a drop in the Russell 2000 Index.

7 jul 2026, 21:41 UTC

Illumina Inc. shares are higher in after-market trading, reflecting ongoing strength despite earlier session pullbacks and broader caution in the technology sector.

Comparación entre iguales

Cambio de precio

Illumina Inc previsión

Precio Objetivo

By TipRanks

-11.15% descenso

Estimación a 12 Meses

Media 194.93 USD  -11.15%

Máximo 230 USD

Mínimo 113 USD

De acuerdo con 15 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Illumina Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

15 ratings

7

Comprar

5

Mantener

3

Vender

Sentimiento

By Acuity

80 / 340 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Illumina Inc

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.
help-icon Live chat